ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.04
      1.10%
      US Tech 100
      21,198.40
      1.36%
      Dow Jones
      43,297.03
      0.91%
      Brent Oil
      73.285
      0.00%
      Bitcoin
      99,249.64
      -0.05%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Shield Therapeutics Plc (STX) Quote

      Shield Therapeutics Plc

      Shield Therapeutics Plc (STX)

      Strike Energy Limited
      Starrex International Ltd
      Seagate Technology Holdings PLC
      2.75
      0.00
      (0.00%)
      Closed December 25 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      2.75
      Bid
      2.70
      Ask
      2.80
      Volume
      333,948
      2.75 Day's Range 2.75
      1.075 52 Week Range 7.65
      Market Cap
      21.324M
      Previous Close
      2.75
      Open
      2.75
      Last Trade
      3577
      @
      2.795
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      2,608,329
      Shares Outstanding
      775,429,360
      Dividend Yield
      -
      PE Ratio
      -0.64
      Earnings Per Share (EPS)
      -0.04
      Revenue
      13.09M
      Net Profit
      -33.29M

      About Shield Therapeutics Plc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.shieldtherapeutics.com
      Headquarters
      Newcastle Upon Tyne, Gbr
      Founded
      -
      Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2.75p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 7.65p.

      Shield Therapeutics currently has 775,429,360 shares outstanding. The market capitalization of Shield Therapeutics is £21.32 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.64.

      Ask ADVFN Intelligence (AI)

      STX Latest News

      More News

      Shield Therapeutics PLC Result of General Meeting & Total Voting Rights

      Shield Therapeutics PLC 24 December 2024   Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   Result of General Meeting and Total Voting Rights   Shareholder approval for $10...

      December 24 2024
      RNS Regulatory News

      Shield Therapeutics PLC Results of RetailBook Offer

      Shield Therapeutics PLC 23 December 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW...

      December 23 2024
      RNS Regulatory News

      Shield Therapeutics to raise USD10.0 million via AOP subscription

      Shield Therapeutics PLC on Friday said it intends to raise USD10.0 million via a share subscription, and launched a r ...

      December 06 2024
      Alliance News

      Shield Therapeutics PLC RetailBook Offer

      Shield Therapeutics PLC 06 December 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW...

      December 06 2024
      RNS Regulatory News

      Shield Therapeutics PLC Subscription by AOP Health to raise US$10 million

      Shield Therapeutics PLC 06 December 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

      December 06 2024
      RNS Regulatory News

      Shield Therapeutics shares up on strong October sales

      Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following ...

      November 21 2024
      Alliance News

      Shield Therapeutics PLC Business Update

      Shield Therapeutics PLC 21 November 2024     Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   Business Update Recruitment completed of the Phase 3 confirmatory Study in...

      November 21 2024
      RNS Regulatory News

      Shield Therapeutics shares slide as it expands financing arrangement

      Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flo ...

      October 29 2024
      Alliance News

      Shield Therapeutics PLC Q3 Trading Update

      Shield Therapeutics PLC 29 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

      October 29 2024
      RNS Regulatory News

      Shield Therapeutics PLC Results from Phase 3 paediatric study

      Shield Therapeutics PLC 25 September 2024     Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   Results from Phase 3 paediatric study   Pivotal Trial of ACCRUFeR®/FeRACCRU®...

      September 25 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0752.803738317762.6752.7752.67516059462.74575562DE
      4-0.1-3.508771929822.853.052.67515808922.82294672DE
      12-1.8-39.56043956044.555.052.62526083293.20505552DE
      260.841.02564102561.955.81.52538850643.42688584DE
      52-3.7-57.36434108536.457.651.07543440503.0530109DE
      156-32.25-92.142857142935511.07525925595.78466228DE
      260-178.25-98.48066298341811901.075182936413.49955257DE

      STX - Frequently Asked Questions (FAQ)

      What is the current Shield Therapeutics share price?
      The current share price of Shield Therapeutics is 2.75p
      How many Shield Therapeutics shares are in issue?
      Shield Therapeutics has 775,429,360 shares in issue
      What is the market cap of Shield Therapeutics?
      The market capitalisation of Shield Therapeutics is GBP 21.32M
      What is the 1 year trading range for Shield Therapeutics share price?
      Shield Therapeutics has traded in the range of 1.075p to 7.65p during the past year
      What is the PE ratio of Shield Therapeutics?
      The price to earnings ratio of Shield Therapeutics is -0.64
      What is the cash to sales ratio of Shield Therapeutics?
      The cash to sales ratio of Shield Therapeutics is 1.63
      What is the reporting currency for Shield Therapeutics?
      Shield Therapeutics reports financial results in USD
      What is the latest annual turnover for Shield Therapeutics?
      The latest annual turnover of Shield Therapeutics is USD 13.09M
      What is the latest annual profit for Shield Therapeutics?
      The latest annual profit of Shield Therapeutics is USD -33.29M
      What is the registered address of Shield Therapeutics?
      The registered address for Shield Therapeutics is NORTHERN DESIGN CENTRE, BALTIC BUSINESS QUARTER, GATESHEAD QUAYS, NEWCASTLE UPON TYNE, NE8 3DF
      What is the Shield Therapeutics website address?
      The website address for Shield Therapeutics is www.shieldtherapeutics.com
      Which industry sector does Shield Therapeutics operate in?
      Shield Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WNWDWindward Ltd
      208.00p
      (42.47%)
      		1.4M
      LDGLogistics Development Group Plc
      14.75p
      (41.83%)
      		2.43M
      TIRTiger Royalties And Investments Plc
      0.175p
      (16.67%)
      		19.85M
      ASTAscent Resources Plc
      2.10p
      (16.67%)
      		2.75M
      LIVLivermore Investments Group Limited
      54.00p
      (16.13%)
      		75.58k
      AMGAtlas Metals Group Plc
      11.00p
      (-61.40%)
      		1.75M
      INDIIndus Gas Limited
      9.00p
      (-25.00%)
      		647.82k
      WEBWebis Holdings Plc
      0.06p
      (-20.00%)
      		5.8M
      SLFRSlf Realisation Fund Limited
      1.00p
      (-19.03%)
      		279.95k
      SYMESupply@me Capital Plc
      0.003p
      (-18.92%)
      		42.63M
      MSMNMosman Oil And Gas Limited
      0.028p
      (-6.67%)
      		568.68M
      NTVONativo Resources Plc
      0.0019p
      (0.00%)
      		393.56M
      SEESeeing Machines Limited
      4.65p
      (0.00%)
      		342.73M
      TRPTower Resources Plc
      0.034p
      (-2.86%)
      		200.58M
      PREMPremier African Minerals Limited
      0.0535p
      (1.90%)
      		150.11M

      Discussion

      View Full Feed
      Hoskuld Hoskuld 1 minute ago
      skitahoe, there is no excuse necessary for approval to occur in Q1 2026 - the standard time to approval brings the decision into JAN/FEB 2026. The UK is a different animal and NWBO is a very different animal - an inferior personalized parenteral medicine cannot be compared to a best-in-class, oral
      NWBO
      janice shell janice shell 1 minute ago
      Speaking of food, have you ever been to Paesanella Cafe in Marrackville?

      https://www.notquitenigella.com/2014/08/20/paesanella-cafe-marrickville/

      Sounds as if you should be getting their cheeses. And they have tons of other Italian stuff. There's also a cafe! Is it near
      delerious1 delerious1 2 minutes ago
      Oh boy...this is not good....

      https://x.com/WhispersNewsLTD/status/1871511171972595724?t=0TcF4cDaxOhiZw_3zI_8_w&s=03
      LORTAP KCOTS LORTAP KCOTS 2 minutes ago
      CEO says $1.40-$1.80 adj. EPS 2025.
      Maybe I misunderstood that statement as something else..?
      WBA
      devil dog 96 devil dog 96 3 minutes ago
      I have sold enough shares on the way up and my remaining position is so green I can care less what happens at opening. 🤑

      "Sell the open and thank me later"

      If you are not playing the dips and rips this CASH COW gives us then your missing out on all the bonus
      RUM RUMBW
      Ecomike Ecomike 7 minutes ago
      Indeed it is sir. Merry Christmas
      IFUS
      OMOLIVES OMOLIVES 7 minutes ago
      What in the hell is Ernest Hemingway doing out in the sticks? I though he was dead.
      delerious1 delerious1 7 minutes ago
      If what I read is correct, there are 14 hours to go before open....still time for some tax loss selling ....and then buying begins.....
      NBRI
      Ecomike Ecomike 8 minutes ago
      Ah, so you are claiming to be an expert on Parrots?

      AI can easily parrot the truth. You just can't stand the truth being posted here on IFUS.
      IFUS
      Louie_Louie Louie_Louie 8 minutes ago
      I was hoping you'd get it! Me wise cracking, no offense intended.
      getmoreshares getmoreshares 9 minutes ago
      have them on IGNORE-- not worth the time to read.
      NBRI
      TradingCharts TradingCharts 10 minutes ago
      Modular extraction apparatus
      Patent number: 12172129
      https://patents.justia.com/assignee/international-battery-metals-ltd
      Abstract: Apparatuses and methods for extracting desired chemical species including, without limitation, lithium, specific lithium species, and/or other chem
      IBATF
      Louie_Louie Louie_Louie 14 minutes ago
      These democrats are all starting to experience God's wrath (Karma) slowly but surely.

      Pelosi - Broken hip, will she deteriorate further?

      Ellen Degenress - moves to London because of Trump, supposedly, many others say because of a failing career. Two weeks in, and afte
      jimr1717 jimr1717 15 minutes ago
      I could care less
      CRSM
      janice shell janice shell 16 minutes ago
      I wouldn't really compare cotechino to pepperoni. First of all, it has a natural casing. And it's thicker. And usually it's eaten hot, with mashed potatoes. Along with several similar kinds of sausage, it's a traditional New Year's Eve dish, served with lentils. the lentils represent coins: you'll b
      Atown62 Atown62 18 minutes ago
      He/her is definitely playing dress up - I'm referring to Eric PARKINSON 
      HHSE
      peanutz peanutz 18 minutes ago
      Me to but I think the new restricted shares are for the new international launch .
      IGPK
      delerious1 delerious1 19 minutes ago
      So with the latest shipments from the Fran mine supplying material to the Bishop Mill to fine-tune all the improvements that have been going on for the last few weeks in the Mill...to get recovered Gold etc as high as possible almost or already complete....

      We all know that there is p
      NBRI
      jimr1717 jimr1717 19 minutes ago
      “ If Neuralink wants to safely implant its chips in the brain, it'll need Si3n4 for its biocombatability and for its anti microbial properties. That said, neural implants will glitch and malfunction just like Musks Tesla already does due to EM radiation”

      Like Pioneer mentioned all the
      SINT
      imafan imafan 20 minutes ago
      Success is IMMINENT!!! Despite sleazeball short naysayers! Newbies with same short mantra, no doubt the return of a familiar loser! Merry Christmas, HHSE on the move, whether scumbag shorts yap or not! ONWARD!!!
      HHSE
      cjstocksup cjstocksup 20 minutes ago
      🚨🇺🇸 WHY CAN’T BIDEN BUILD ANYTHING?

      He promised 500,000 EV chargers - 2 years later, they'd built 7.

      That’s one per $1B spent.

      The $65B broadband push? Zero projects launched.

      Private companies are laying cable whi
      cjstocksup cjstocksup 20 minutes ago
      🚨🇺🇸 WHY CAN’T BIDEN BUILD ANYTHING?

      He promised 500,000 EV chargers - 2 years later, they'd built 7.

      That’s one per $1B spent.

      The $65B broadband push? Zero projects launched.

      Private companies are laying cable whi

      Your Recent History

      LSE
      STX
      Shield Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads